Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
5-MeO-DiBF
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Effects vary widely by individual, dose, and context.
Physical
Cognitive
The head space of 5-MeO-DiBF is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high doses. The total sum of these cognitive components (regardless of the setting) generally includes:
Visual
Geometry
The visual geometry that is present throughout the experience can be described as more similar in appearance to that of 5-MeO-DALT or AMT than that of LSD, 2C-B or 2C-I. It can be comprehensively described as unstructured in its organization, synthetic in geometric style, intricate in complexity, small in size, slow and smooth in motion, colourful in scheme, glossy in colour, equally blurred and sharp in its edges and equally rounded and angular in its corners. It gives off a synthetic feel that is less impressive than most of the "classical" psychedelics at any level. It has yet to be confirmed whether this compound results in either level 8A or level 8B geometry at heavy doses.
Auditory
See also: Psychedelic Intensity Scale, Effects of psychedelics (visual, cognitive, miscellaneous)
Pharmacology
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
Higher doses may increase adverse effects, including possible addiction-related concerns, but 5-MeO-DiBF-specific addiction risk has not been characterized.
Toxicity
The exact toxic dose is described as unknown, and recreational toxicity and long-term health effects are said not to have been scientifically studied.
Increased heart rate is listed among physical effects.
Muscle spasms are listed among physical effects.
Temperature regulation suppression is listed among physical effects.
Psychosis Risk
Psychosis risk is specifically warned for lithium combinations and may be increased by cannabis or stimulant combinations.
Seizure Risk
Lithium is warned to significantly increase psychosis and seizure risk, and tramadol may lower the seizure threshold enough for psychedelics to trigger seizures in susceptible people.
History & Culture
Legality
International
Controlled internationally under the UN Convention on Psychotropic Substances 1971.
By Country
References
Source Pages
Bluelight: Pellets & higher-dose reports (2016-2023)
Bluelight: Small & Handy 5-MeO-DiBF thread (2015)
Drug Users Bible by Dominic Milton Trott
Drug Users' Bible - 5-MeO-DiBF page
Erowid: Experience Reports - 5-MeO-DiBF
Isomer Design (TiHKAL/PiHKAL)
PsychonautWiki
TripSit Factsheets
Turn-in descriptions of 5-MeO-DiBF pellets (Bluelight user BathSalts, 2016)
Wikimedia media description - forensic ID (2015)
Wikipedia
Citations
- PubChem PUG REST: 5-MeO-DiBF (CID 125276632). pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/125276632/property/IUPACName,MolecularFormula,MolecularWeight,CanonicalSMILES,InChIKey/JSON1
- Sechste Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes, BGBl. 2025 I Nr. 292. recht.bund.de (n.d.). https://www.recht.bund.de/bgbl/1/2025/292/regelungstext.pdf?__blob=publicationFile&v=11
- Federal Ministry of Health draft and explanatory memorandum, Sixth Regulation Amending the Schedule to the NpSG. bundesgesundheitsministerium.de (n.d.). https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/Gesetze_und_Verordnungen/GuV/N/RefE_6._VO_zur_AEnderung_NpSG_Anlage.pdf1
- Deutscher Bundestag Drucksache 18/8579: Entwurf eines Gesetzes zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe. dserver.bundestag.de (n.d.). https://dserver.bundestag.de/btd/18/085/1808579.pdf1
- Neue-psychoaktive-Stoffe-Gesetz (NpSG), § 2 Begriffsbestimmungen. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/__2.html1
- Neue-psychoaktive-Stoffe-Gesetz (NpSG), § 3 Unerlaubter Umgang mit neuen psychoaktiven Stoffen. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/__3.html1
- Neue-psychoaktive-Stoffe-Gesetz (NpSG), § 4 Strafvorschriften. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/__4.html1
- Neue-psychoaktive-Stoffe-Gesetz (NpSG), current consolidated text. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/BJNR261510016.html1
- Betäubungsmittelverzeichnisverordnung (BetmVV-EDI), Stand am 13. März 2026, Anhang 6, Verzeichnis e. fedlex.data.admin.ch (n.d.). https://fedlex.data.admin.ch/filestore/fedlex.data.admin.ch/eli/cc/2011/363/20260313/de/html/fedlex-data-admin-ch-eli-cc-2011-363-20260313-de-html-3.html1
- Änderung der Betäubungsmittelverzeichnisverordnung vom 1. November 2016, AS 2016 4197. fedlex.data.admin.ch (n.d.). https://fedlex.data.admin.ch/filestore/fedlex.data.admin.ch/eli/oc/2016/705/de/pdf-a/fedlex-data-admin-ch-eli-oc-2016-705-de-pdf-a.pdf1
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 5-MeO-DiBF article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.